Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

COVID-19 vaccination may trigger lupus in some people.

Taking biotin supplements can cause incorrect thyroid test results, leading to wrong diagnoses.

A woman with severe angioedema improved significantly after treatment with rituximab.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Researchers found a safe and effective way to pick genetically modified skin cells with high growth potential using CD24.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Activating c-Myc in skin causes rapid cell growth and changes, but these effects are reversible.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Lambs' skin showed similar but more severe responses to a second orf virus infection, involving immune cells and new skin formation.

A woman with lupus had hair loss and skin issues that were successfully treated with medications.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Harlequin mutant mice have hair loss due to low AIF protein levels and retroviral element activity.

Certain human skin cells marked by CD44 and ALDH are rich in stem cells capable of long-term skin renewal.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.